✦ LIBER ✦

Cost-Effectiveness Analysis of Apixaban in the Treatment of Atrial Fibrillation in Mexico

✍ Scribed by Galindo-Suárez, R.M.; Davila-Veites, A.; Olguin-Sánchez, J.F.; Haddad, A.; del Angel- Martínez, J.; Muciño-Ortega, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atrial fibrillation: Apixaban cost-effec

✍ Miettinen, O. S. 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 44 KB

Estimation of the Cost-Effectiveness of

✍ Giorgi, M.A.; Caroli, C.; Micone, P.; Giglio, N.D.; Aiello, E.C.; Donato, B.M.K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

COST-EFFECTIVENESS OF APIXABAN COMPARED

✍ Soyon Lee; Moise Anglade; Kelly Hagstrom; Joy Meng; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Cost-Effectiveness of Apixaban Versus Ot

✍ Lip, Gregory Y.H.; Kongnakorn, Thitima; Phatak, Hemant; Kuznik, Andreas; Lanitis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 904 KB

Cost-Effectiveness Analysis of Apixaban

✍ Betegón Nicolás, L.; Escolar Albaladejo, G.; Canal Fontcuberta, C.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB